2017 Archived Content

Distinguished Faculty

Tressa Allington, Ph.D., Development Scientist, Bioanalytical Development, Alexion Pharmaceuticals

Robyn Beckwith, Ph.D., Associate Scientist, Analytical Development and Quality Control, Product Technical Development, Genentech

Anne Benoit, Ph.D., Expert Biostatistician, Biostatistics and Statistical Programming, Non-Clinical R&D Statistics – CLS, Clinical Evidence Generation, GSK Vaccines

Erica Bortolotto, Ph.D., Senior Scientist, Bioassay Development, Analytical Sciences for Biologicals, UCB PHARMA

Xiaoying Chen, Ph.D., Senior Manager, Early Oncology Development & Clinical Research, Pfizer, Inc.

Shan Chung, Ph.D., Senior Scientist and Group Leader, BioAnalytical Sciences, Genentech, Inc.

Jim Cook, Immunology Sales Specialist, Sales, ProImmune Inc

Viswanath Devanarayan, Ph.D., Executive Director and Head, Global Statistics, Charles River Labs

Rakesh Dixit, Ph.D., Vice President, R&D, Global Head, Biologics Safety Assessment, MedImmune, Inc.

Mark Fogg, Group Leader, Immunology, Abzena

Jochem Gokemeijer, Ph.D., Associate Director, Molecular Discovery Technology, Bristol-Myers Squibb

Theresa Goletz, Ph.D., Director, Clinical Immunology, EMD  Serono

Ulrike Herbrand, Ph.D., Scientific Supervisor Research & Development, Biosafety & Bioassay Services, Charles River Labs

Vibha Jawa, Ph.D., Director, Biologics and Vaccines Bioanalytics, Merck and Co., Inc.

Marisa K. Joubert, Ph.D., Principal Scientist, Process Development, Amgen, Inc.

Martin Kane, MS, CRE, Managing Data Scientist, Statistical and Data Sciences Practice, Exponent

Susan Kirshner, Ph.D., Associate Chief, Immunology Lab, Therapeutic Proteins, Biotechnology, FDA/CDER

Kei Kishimoto, Ph.D., CSO, Selecta Biosciences

Priya S. Kishnani, M.D., Division Chief & Director, Genetics and Genomics Center, Department of Pediatrics, Duke University

Natalia Kozhemyakina, Ph.D., Head, Bioassay Laboratory, Analytical Development Department,  BIOCAD

Robert J. Kubiak, Ph.D., Senior Manager, R&D, Translational Science, MedImmune LLC

Steven J. Kussick, M.D., Ph.D., CMO, Director, Contract Research and Flow Cytometry, PhenoPath Laboratories; Clinical Assistant Professor, Laboratory Medicine, University of Washington

Mike Lacy, Ph.D., Associate Director, Immunology, Emergent Biosolutions

David Lansky, Ph.D., President, Precision Bioassay, Inc.

Maria Libera Ascierto, Ph.D., Post Doc Fellow, Oncology, Johns Hopkins University

Thomas Little, Ph.D., President, Bioassay Sciences, Thomas A. Little Consulting

LeeAnn Machiesky, Scientist,  MedImmune

Mauricio Maia, Ph.D., Senior Scientist, BioAnalytical Sciences, Genentech, Inc.

David Margulies, M.D., Ph.D., Senior Investigator, Molecular Biology, Niaid/DIR

Rachid Marhaba, Ph.D., Senior Scientist, Clinical Laboratory Sciences, GSK Vaccines GmbH

Ronit Mazor, Ph.D., Post-Doctoral Fellow, Molecular Biology, National Cancer Institute

Jim McNally, Ph.D., Head, Clinical Bioanalysis and QPD Program Rep, Quantitative Pharmacology and Drug Disposition, EMD Serono

Keith Merdek, Ph.D., Principal Scientist, Bioanalytical Sciences & Biomarkers, Sanofi

Paul Moore, Ph.D., Vice President, Cell Biology & Immunology, Macrogenics, Inc.

Tony Navas, Ph.D., Senior Scientist, Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research

Jennifer Ohayon, Ph.D., Scientific Director, Eurofins Bioanalytical Services

Michael Partridge, Ph.D., Staff Scientist, Bioanalytical Sciences, Regeneron, Inc.

Ravish Patel, Ph.D., Manager, Quality Control, Epygen Biotech

Sofie Pattijn, CTO, ImmunXperts

Joao Pedras-Vasconcelos, Ph.D., Biotech Quality and Immunogenicity Reviewer, Office of Biotechnology Products, CDER-FDA

Alpana Prasad, Ph.D., Product Manager, DiscoverX Corporation

Kathleen P. Pratt, Ph.D., Associate Professor, Medicine, Uniformed Services, University of the Health Sciences

Amy S. Rosenberg, M.D., Division Director, Office of Biotechnology Products, FDA/CDER

Bonita (Bonnie) Rup, Ph.D., Biopharmaceutical Consultant, Bonnie Rup Consulting

Laura I. Salazar-Fontana, Ph.D., Associate Director, Biomarkers and Clinical Bioanalysis, Translational Medicine and Early Development, Sanofi

Becky Schweighardt, Ph.D., Director, Immunogenicity Assessment, Biomarin Pharmaceutical, Inc.

Ethan Shevach, M.D., Senior Investigator, Immunology, National Institute of Allergy and Infectious

Diseases, National Institutes of Health

Noel Smith, Ph.D., Senior Group Leader, Applied Protein Services, Lonza Biologics, plc

Veerle Snoeck, Ph.D., Principal Scientist, Pharmacology, Immunogenicity, Ablynx BV

Perceval Sondag, Principal Statistician, Non-Clinical Statistics,  Arlenda

Priya Sriraman, Ph.D., Principal Investigator, Non-Clinical Development, Celgene  Corp

Lauren Stevenson, Ph.D., Director, Development Biomarkers and Bioanalytical Sciences, Biogen, Inc.

Sandra Thiemann, Ph.D., Scientist, Bio-Immunoassay Group, Attribute Sciences, Amgen

Daniela Verthelyi, Ph.D., Chief, Immunology Lab, Therapeutic Proteins, FDA/CDER

Junxia Wang, Ph.D., Associate Director, Immunosafety and Bioanalytical Development, Editas Medicine

Wendy White, Ph.D., Scientific Director & Fellow, Clinical Pharmacology, MedImmune, Inc.

Yuanxin Xu, Ph.D., Senior Scientific Director, Clinical Assay Development, Clinical Lab Sciences, Alnylam Pharmaceuticals

Rong Zeng, Ph.D., Director, Bioanalytical Sciences,  OncoMed Pharmaceuticals

Jad Zoghbi, Ph.D., Senior Scientist, Biomarkers and Clinical Bioanalysis, Sanofi


Speaker Proposal

CONFERENCE PROGRAMS